These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases. Ruiz de Souza V; Kaveri SV; Kazatchkine MD Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005 [TBL] [Abstract][Full Text] [Related]
10. IVIG as a nonspecific accelerator of restitutio ad integrum. Rewald E Transfus Sci; 2000 Oct; 23(2):163-4. PubMed ID: 11035277 [No Abstract] [Full Text] [Related]
12. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases. Hurez V; Kaveri SV; Kazatchkine MD J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immune globulin in autoimmune and inflammatory diseases. Gelfand EW N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098 [No Abstract] [Full Text] [Related]
14. Intravenous immunoglobulin therapy in dermatologic disorders. Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin: implications for use in the neurological patient. Chipps E; Skinner C J Neurosci Nurs; 1994 Feb; 26(1):8-17. PubMed ID: 8195653 [TBL] [Abstract][Full Text] [Related]
16. [Intravenous immunoglobulins (IgIV) in the treatment of autoimmune diseases and systemic inflammatory diseases]. Kazatchkine M Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):209-10. PubMed ID: 8337128 [No Abstract] [Full Text] [Related]
17. Practical considerations for the use of IGIV therapy: introduction. Shah S Am J Health Syst Pharm; 2005 Aug; 62(16 Suppl 3):S3-4. PubMed ID: 16100385 [No Abstract] [Full Text] [Related]